Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Vaishali Sanchorawala, MD
Healthcare Professional Director
Amyloidosis Center
Boston University School of Medicine
72 East Concord Street
Boston, Massachusetts, United States
Vaishali Sanchorawala is the Director of the Autologous Stem Cell Transplantation Program at Boston Medical Center and has been affiliated with the Amyloidosis Center of the Boston University School of Medicine since 1994 and recently has been appointed as Director of the Center. She has been one of the pioneers in the field of clinical research in AL amyloidosis and her work in the treatment of systemic AL amyloidosis has been published in many peer-reviewed journals, which has resulted in the evolution of the standard of care for patients.
Dr. Sanchorawala received her MBBS and postdoctoral training from the Seth G.S. Medical College, Bombay University, India, and completed her fellowship in hematology and oncology at Boston University Medical Center in 1997 when she joined Boston University School of Medicine as an Assistant Professor of Medicine and BMC as an attending physician. She was promoted to Associate Professor in 2005 and Professor in 2011.
Dr. Sanchorawala serves on the board of the International Society of Amyloidosis as an associate editor of Amyloid, Journal of Protein Folding Disorders, and as a member of the Executive Steering Committee of Amyloidosis Research Consortium. She has also participated in FDA meetings to enhance the amyloidosis drug development pathway for more effective treatments.
Representative Publications:
myBinderRelated Content
-
Clarification on the Definition of Complete Haematologic Response in Light-Chain (AL) AmyloidosisThe International Society of Amyloidosis...
-
Manisha Bhutani, MDDr. Manisha Bhutani is an oncologist a...
-
Muzaffar H. Qazilbash, MDMuzaffar Qazilbash is a Professor of med...
-
Stacey A. Goodman, MDStacey A. Goodman is a Professor of Medi...
-
Daratumumab-Based Therapies in Patients With AL AmyloidosisBackground: Treatment options for patie...
-
The Challenges in Chemotherapy and Stem Cell Transplantation for Light-Chain AmyloidosisLight-chain (AL) amyloidosis is a system...
-
At Least Partial Hematological Response After First Cycle of Treatment Predicts Organ Response and Long-term Surviva...AL amyloidosis is a rare plasma cell dys...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
